Acutus Medical Inc, a medical device maker for atrial arrhythmias, has filed Amendment No 1 to Form S-1 Registration Statement on July 30, 2020 with the U.S Securities and Exchange Commission to announce terms for its IPO.
The company plans to raise $125 million by offering 7.4 million shares at a price range of $16 to $18. Assuming a successful IPO at the midpoint of the proposed range, the company expects a market capitalization of $457 million.
The dynamic arrhythmia care company makes imaging and other products and therapies related to heart rhythm disorders. It is expending its product portfolio includes the AcQMap imaging and mapping system.
The Carlsbad, California-based company was founded in 2011 and booked $4 million in sales for the 12 months ended March 31, 2020. The company plans to list on the Nasdaq Global Market under the symbol “AFIB.” J.P. Morgan and BofA Securities are underwriters of the IPO.
The company engages Davis Polk & Wardwell LLP as US Securities Counsel, and KPMG LLP as Independent Auditor.
#ipo #nasdaq #sec #arrhythmia #healthcare #KPMG #jpmorgan #Acutus
Hexcellence Consulting has experienced IPO consulting team focus on listing in US Stock Market,
namely NYSE, Nasdaq and OTC Markets.
Should you interested to list your company in US Stock Market,
please contact us at [email protected].